Thyme Care, a Nashville TN-based provider of oncology care management solutions, raised $22M in funding.
The round was led by Andreessen Horowitz, AlleyCorp, and Frist Cressey Ventures with participation from Casdin Capital and Bessemer.
The company intends to use the funds to accelerate the technology and advance partnerships with oncologists, health plans, employers, and risk-based entities.
Led by Robin Shah, Founder and CEO, Thyme Care provides a complete tech-enabled oncology care management solution for health plans, including partnership with Clover Health, offerinf tech-enabled cancer care navigation. The platform, which connects patients, caregivers, providers, and payers, generates actionable insights that enable identification of individuals early in the cancer journey, while optimizing the patient experience and empowering clinicians to be able to better serve patients’ needs at scale. With Thyme Care, every member is assigned a personalized team of oncology nurses and resource specialists who provide education, guidance, and advocacy as they navigate their care.
The company’s board of directors includes:
- Vineeta Agarwala, MD, PhD, General Partner at Andreessen Horowitz
- Brenton Fargnoli, MD, Managing Partner of AlleyCorp Healthcare Fund
- Senator Bill Frist, MD, Co-Founder and Partner of Frist Cressey Ventures (Board Observer)
- Bobby Green, MD, President and Chief Medical Officer of Thyme Care
- Vivek Garipalli, CEO and Co-Founder of Clover Health
- Puneet Singh, CEO of Quartet Health
- Robin Shah, Founder and CEO of Thyme Care
FinSMEs
05/10/2021